LENSAR Inc
NASDAQ:LNSR

Watchlist Manager
LENSAR Inc Logo
LENSAR Inc
NASDAQ:LNSR
Watchlist
Price: 13.14 USD 1.86% Market Closed
Market Cap: 154.9m USD

Relative Value

The Relative Value of one LNSR stock under the Base Case scenario is 10.63 USD. Compared to the current market price of 13.14 USD, LENSAR Inc is Overvalued by 19%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

LNSR Relative Value
Base Case
10.63 USD
Overvaluation 19%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
22
vs Industry
36
Median 3Y
1.2
Median 5Y
1.7
Industry
2.3
Forward
2.2
vs History
vs Industry
Median 3Y
-2.9
Median 5Y
-3.3
Industry
22
Forward
-33
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-5.8
Industry
14.3
vs History
vs Industry
Median 3Y
-5.4
Median 5Y
-7.1
Industry
20
vs History
vs Industry
7
Median 3Y
0.9
Median 5Y
1.2
Industry
2.2
vs History
8
vs Industry
40
Median 3Y
0.8
Median 5Y
1
Industry
2.4
Forward
1.9
vs History
6
vs Industry
40
Median 3Y
1.6
Median 5Y
1.9
Industry
5
vs History
vs Industry
58
Median 3Y
-2.3
Median 5Y
-2.4
Industry
11.6
Forward
-254.3
vs History
vs Industry
54
Median 3Y
-1.9
Median 5Y
-2.1
Industry
15.9
Forward
-25.4
vs History
vs Industry
57
Median 3Y
-3.8
Median 5Y
-3.8
Industry
14.3
vs History
vs Industry
46
Median 3Y
-3.7
Median 5Y
-3.7
Industry
18
vs History
6
vs Industry
21
Median 3Y
0.8
Median 5Y
1.1
Industry
1.8

Multiples Across Competitors

LNSR Competitors Multiples
LENSAR Inc Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
US
LENSAR Inc
NASDAQ:LNSR
154.9m USD 2.7 -2.7 -13.6 -9.5
US
Abbott Laboratories
NYSE:ABT
228.1B USD 5.4 16.9 21.9 31.5
US
Intuitive Surgical Inc
NASDAQ:ISRG
183.7B USD 21.1 74.2 59.8 72.7
US
Boston Scientific Corp
NYSE:BSX
152.6B USD 8.7 75.1 35.4 49.3
US
Stryker Corp
NYSE:SYK
149.4B USD 6.4 52.2 25.8 31.1
IE
Medtronic PLC
NYSE:MDT
115.1B USD 3.4 24.7 13.8 19.6
DE
Siemens Healthineers AG
XETRA:SHL
52.2B EUR 2.3 25 14 19.4
US
Becton Dickinson and Co
NYSE:BDX
51.1B USD 2.4 33.6 13.4 25
US
Edwards Lifesciences Corp
NYSE:EW
44.8B USD 8.1 10.7 24.5 27
US
IDEXX Laboratories Inc
NASDAQ:IDXX
42B USD 10.7 47 33.3 37.2
US
Resmed Inc
NYSE:RMD
37.3B USD 7.4 28.4 20.3 23
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
US
LENSAR Inc
NASDAQ:LNSR
Average EV/EBITDA: 26.2
Negative Multiple: -13.6
N/A N/A
US
Abbott Laboratories
NYSE:ABT
21.9
13%
1.7
US
Intuitive Surgical Inc
NASDAQ:ISRG
59.8
24%
2.5
US
Boston Scientific Corp
NYSE:BSX
35.4
21%
1.7
US
Stryker Corp
NYSE:SYK
25.8
12%
2.2
IE
Medtronic PLC
NYSE:MDT
13.8
7%
2
DE
Siemens Healthineers AG
XETRA:SHL
14
14%
1
US
Becton Dickinson and Co
NYSE:BDX
13.4
11%
1.2
US
Edwards Lifesciences Corp
NYSE:EW
24.5
12%
2
US
IDEXX Laboratories Inc
NASDAQ:IDXX
33.3
12%
2.8
US
Resmed Inc
NYSE:RMD
20.3
12%
1.7
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
US
LENSAR Inc
NASDAQ:LNSR
Average EV/EBIT: 33.6
Negative Multiple: -9.5
N/A N/A
US
Abbott Laboratories
NYSE:ABT
31.5
22%
1.4
US
Intuitive Surgical Inc
NASDAQ:ISRG
72.7
26%
2.8
US
Boston Scientific Corp
NYSE:BSX
49.3
31%
1.6
US
Stryker Corp
NYSE:SYK
31.1
16%
1.9
IE
Medtronic PLC
NYSE:MDT
19.6
15%
1.3
DE
Siemens Healthineers AG
XETRA:SHL
19.4
19%
1
US
Becton Dickinson and Co
NYSE:BDX
25
28%
0.9
US
Edwards Lifesciences Corp
NYSE:EW
27
12%
2.3
US
IDEXX Laboratories Inc
NASDAQ:IDXX
37.2
12%
3.1
US
Resmed Inc
NYSE:RMD
23
14%
1.6